Document is current

Any future updates will be listed below

Cardiovascular adverse events and immune-related adverse events associated with PD-1/PD-L1 inhibitors for head and neck squamous cell carcinoma (HNSCC)

Crossref DOI link: https://doi.org/10.1038/s41598-024-75099-5

Published Online: 2024-10-29

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark